Vertex Pharmaceuticals Incorporated Common Stock (VRTX)

About VRTX

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

6,400

Website

www.vrtx.com/

Fundamentals

1-day range

$540.1$549.57

Market cap

$122.68B

P/E (trailing)

30.70

P/E (forward)

24.63

EPS (trailing)

$17.19

Dividend yield

—

Beta

0.27

Avg. volume

1.51M

Forecasts

25 analyst ratings

Vertex Pharmaceuticals Incorporated Common Stock Competitors

Chosen by industry and closest market cap.

• VRTX

  Vertex Pharmaceuticals Incorporated Common Stock

  $541.72

  ▼ 1.06%
  Market cap $122.68BP/E 30.70
  $374.17$555.69
• GSK

  GSK plc American Depositary Shares (Each representing two Ordinary Shares)

  $50.82

  ▲ 1.09%
  Market cap $105.65BP/E 15.53
  $1,441$2,282
• SNY

  Sanofi ADS

  $44.82

  ▼ 0.04%
  Market cap $104.60BP/E 16.24
  $71.25$91.15
• PFE

  Pfizer Inc. Common Stock

  $27.95

  ▼ 0.25%
  Market cap $149.33BP/E 35.19
  $23.58$28.75
• REGN

  Regeneron Pharmaceuticals Inc. Common Stock

  $793.96

  ▼ 1.70%
  Market cap $79.49BP/E 18.98
  $541$847
• ABT

  Abbott Laboratories Common Stock

  $112.42

  ▲ 0.74%
  Market cap $186.81BP/E 35.52
  $81.97$137.49
• TAK

  Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

  $18.04

  ▲ 0.06%
  Market cap $53.78BP/E —

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
  benzinga · 8/27/2026
• Uber, ServiceNow And A Health Care Stock On CNBC’s ‘Final Trades’
  Benzinga · 8/21/2026
• Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
  Yahoo · 8/20/2026
• Are Wall Street Analysts Bullish on Vertex Stock?
  Yahoo · 8/20/2026
• HEALWELL AI's DARWEN(TM) AI Platform Nominated for 2026 International Prix Galien, the Global "Best of the Best" in Life Sciences Innovation
  Yahoo · 8/19/2026
• Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project
  Yahoo · 8/18/2026
• 3 Cash-Producing Stocks on Our Watchlist
  Yahoo · 8/18/2026
• Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?
  Yahoo · 8/14/2026
• Is Vertex Pharmaceuticals (VRTX) Fairly Valued As Pipeline Catalysts Near?
  Yahoo · 8/14/2026

• Ourania Tatsis · July 21, 2026 · Grant

  8.3K
• Amit Sachdev · July 21, 2026 · Grant

  8.3K
• Alan M. Garber · July 15, 2026 · Grant

  32 @ $475.28
• SACHS BRUCE I · July 15, 2026 · Grant

  100 @ $475.28
• Duncan McKechnie · July 2, 2026 · Sale

  1.5K @ $519
• Ourania Tatsis · July 2, 2026 · Sale

  1.5K @ $524.99
• Joy Liu · July 1, 2026 · Sale

  828 @ $502.71
• Carmen Bozic · June 18, 2026 · Sale

  1.0K @ $462.17
• Carmen Bozic · June 5, 2026 · Sale

  1.7K @ $450
• Joy Liu · June 1, 2026 · Sale

  828 @ $439.91
• Carmen Bozic · May 29, 2026 · Sale

  2.0K @ $450
• Mark E. Bunnage · May 15, 2026 · Sale

  33 @ $453.45
• Carmen Bozic · May 15, 2026 · Sale

  1.4K @ $453.45
• Carmen Bozic · May 12, 2026 · Sale

  7.0K @ $450
• Sangeeta N. Bhatia · May 4, 2026 · Sale

  318 @ $423.73

Institutional Ownership

March 31, 2026

Total shares held

220.10M

Total value held

$95.91B

Institutional holders

1663